Marijuana Use Clinical Trial
Official title:
Opioid Antagonism Enhances Marijuana's Effects in Heavy Marijuana Smokers
The purpose of this study is to determine if the subjective effects of marijuana will be decreased by low-doses (< 25 mg) of naltrexone and increased by high-doses (> 50 mg) of naltrexone.
Laboratory animal studies demonstrate that endogenous cannabinoids and opioids are closely inter-related. We have completed a series of studies in marijuana smokers showing that a clinically-utilized dose of naltrexone (50 mg) enhanced the reinforcing and subjective effects of orally-administered tetrahydrocannabinol (THC), while a low naltrexone dose (12 mg) blunted the effects of THC. A better understanding of the effects of a range of naltrexone doses in combination with smoked marijuana has important implications for the following reasons: (1) Alcohol- and opioid-dependent patients receive high doses of naltrexone (50-150 mg), which may increase the abuse liability of marijuana, (2) Low-dose naltrexone blunts THC's intoxicating effects, suggesting potential utility as a treatment medication for marijuana dependence. This study will determine if naltrexone (0, 12, 25, 50, 100 mg) administration 45 min prior to marijuana administration (0, 3.27% THC) alters marijuana's subjective, cognitive or physiological effects. Marijuana smokers will spend approximately 5h/day for a total of 10 days in the outpatient laboratory. Participants will visit the outpatient laboratory 2-3 times per week, with a minimum 48-hr interval between sessions to allow for naltrexone clearance. These data will provide important information regarding the clinical use of naltrexone. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT01329315 -
Project Chill: Tailored Youth Drug Intervention In Primary Care
|
N/A | |
Completed |
NCT02837315 -
Improving Brief Marijuana Interventions With a Behavioral Economic Supplement
|
N/A | |
Completed |
NCT02387489 -
A Clinical Trial of SBIRT Services in School-based Health Centers
|
N/A | |
Recruiting |
NCT05309226 -
Cannabis Use in Pregnancy and Downstream Effects on Maternal and Infant Health
|
||
Active, not recruiting |
NCT04617938 -
TACUNA (Traditions and Connections for Urban Native Americans)
|
N/A | |
Completed |
NCT02530645 -
Development and Testing of a Smartphone Application to Reduce Substance Use and Sexual Risk Among Homeless Young Adults
|
N/A | |
Completed |
NCT02290938 -
Motivational Interviewing and Culture for Urban Native American Youth (MICUNAY)
|
N/A | |
Completed |
NCT01473719 -
Emerging Adults Who Use Alcohol and Marijuana
|
Phase 3 | |
Not yet recruiting |
NCT06077292 -
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
|
N/A | |
Completed |
NCT05362357 -
iSTART: A Campus & Community Initiative for Services in Tec-health
|
N/A | |
Recruiting |
NCT05485012 -
Reinforcing Effects of Marijuana and Opioids
|
Phase 1 | |
Completed |
NCT04965012 -
Testing the Efficacy of an Online Treatment Program for Heavy Cannabis Use
|
N/A | |
Recruiting |
NCT04827992 -
Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain
|
N/A | |
Completed |
NCT04968275 -
A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early Psychosis
|
N/A | |
Completed |
NCT04783519 -
Research Evaluating Sleep & Trends for Universal Prevention
|
N/A | |
Recruiting |
NCT05324813 -
Examining Effects of Domain Specific Episodic Future Thinking on Cannabis Use
|
N/A | |
Recruiting |
NCT04737772 -
Project CheckUP: A Brief Behavioral Intervention for Quitline Callers Who Use Marijuana (MJ) and Tobacco
|
N/A | |
Not yet recruiting |
NCT04855526 -
THC + CBD and Memory Study
|
Early Phase 1 |